Ulla Seppälä

682 citations
19 papers · 499 · 1 hit paper · h-index 13

Impact in

Papers in

Ulla Seppälä

19 papers receiving 450 citations

Ulla Seppälä's Hit Papers

A phase 2a trial of the IL-33 monoclonal antibody tozorakimab in patients with COPD: FRONTIER-4 2025 · 38 citations
380Years since publication102030

Peers

Ulla Seppälä
Comparison fields: 5 of 44
  • Immunology and Allergy 271
  • Dermatology 35
  • Food Science 42
  • Genetics 43
  • Spectroscopy 21
Replace Arnd Petersen with:
Arnd Petersen Germany
Kohsuke Kino Japan
Annabelle M. Watts Australia
Maxime Le Mignon France
Francisco Javier García-Sellés Spain
S. Vieths Germany
W.M. Becker Germany
Reinhold Hirschwehr Austria
Tanja Kalic Austria
Nicole Wopfner Austria
Ulla Seppälä relative to Arnd Petersen Germany Arnd Petersen's profile →
Citations per field
00.5×2×4×6×8×9×
Arnd Petersen · 1×
Citations per year

Countries citing papers authored by Ulla Seppälä

Since Specialization
Citations

This map shows the geographic impact of Ulla Seppälä's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulla Seppälä with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulla Seppälä more than expected).

Fields of papers citing papers by Ulla Seppälä

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ulla Seppälä. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulla Seppälä. The network helps show where Ulla Seppälä may publish in the future.

Co-authors

The 25 scholars most cited alongside Ulla Seppälä, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ulla Seppälä Line = papers co-authored together Ulla Seppälä links everyone, so they are left out of the graph.

All Works

19 of 19 papers shown
#Work
1 199971
2 200659
3 200049
4 200340
5 200138
6
A phase 2a trial of the IL-33 monoclonal antibody tozorakimab in patients with COPD: FRONTIER-4
Hit paper breakdown →
202538
7 200532
8 201130
9 200927
10 200423
11 200120
12 201320
13 201619
14 200413
15 201113
16 20054
17 20001
18 20061
19 20171

About Ulla Seppälä

Ulla Seppälä is a scholar working on Immunology and Allergy, Dermatology, Physiology, Pulmonary and Respiratory Medicine and Pharmacology, having authored 19 papers that have together received 499 indexed citations. Recurring topics across this work include Food Allergy and Anaphylaxis Research (12 papers), Allergic Rhinitis and Sensitization (10 papers), Contact Dermatitis and Allergies (2 papers), Asthma and respiratory diseases (2 papers), Glycosylation and Glycoproteins Research (2 papers), Advanced Proteomics Techniques and Applications (1 paper), Health Systems, Economic Evaluations, Quality of Life (1 paper) and Cystic Fibrosis Research Advances (1 paper). The work is most often cited by research in Immunology and Allergy (271 citations), Dermatology (35 citations), Food Science (42 citations), Genetics (43 citations) and Spectroscopy (21 citations). Ulla Seppälä has collaborated with scholars based in Denmark, Finland and United States. Frequent co-authors include Timo L. Reunala, Nisse Kalkkinen, Timo Palosuo, Kristiina Turjanmaa, Michael Dho Spangfort, Harri Tapio Alenius, Kristiina Turjanmaa, Timo Palosuo, Rafaél I. Monsalve and Christof Ebner. Their work appears in journals such as Journal of Allergy and Clinical Immunology, Allergy, European Journal of Immunology, Journal of Proteome Research and European Respiratory Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact